How can nurses spot the signs of early-stage dementia?
Intended for healthcare professionals
Evidence and practice Previous     Next

How can nurses spot the signs of early-stage dementia?

Sam Olden Consultant practitioner (rehabilitation and frailty), Wiltshire Health and Care, Chippenham, England

Timely dementia diagnosis has been flagged as a target in primary care. Get to know the symptoms to ensure early detection

Dementia is an overarching term associated with a reduction in brain cognition. There are more than 200 subtypes of dementia, impairing multiple cognitive, social and occupational functions (Arvanitakis et al 2019, Dementia UK 2023).

Nursing Older People. 36, 5, 20-21. doi: 10.7748/nop.36.5.20.s9

Peer review

This article has been subject to external double-blind peer review and has been checked for plagiarism using automated software

Published: 30 September 2024

There are an estimated 724,081 people aged over 65 years who have dementia in England (Department of Health and Social Care (DHSC) 2024), with an estimated 47 million worldwide (Arvanitakis et al 2019). Early detection of dementia is key and a target has been set to have a formal diagnosis for at least two thirds (66.7%) of people estimated to be living with the disease (DHSC 2024).

nop_v36_n5_9_0001.jpg

Picture credit: iStock

Working in any healthcare setting means that healthcare professionals may be the first clinical contact with a person who is showing signs of early-stage dementia. Therefore, it is important to be aware of symptoms, risk factors and how to assess or where to direct the patient for further investigations.

Common symptoms

Early signs of dementia vary by pathology and the individual. Common symptoms include occasional memory loss, difficulty finding words, apathy or depressive symptoms, withdrawal from social engagement or change in physical function such as gait impairment, repetitive purposeless movements or frequent falls (Arvanitakis et al 2019).

Each subset of dementia is affected differently by risk factors, however several risk factors are common among dementia syndromes. These include a history of smoking, alcohol intake, hypertension, obesity, hyperlipidaemia and metabolic disease. It has been identified that the presence of three of these risk factors more than doubles the risk of developing dementia (Peters et al 2019).

Often, a specialist review is needed to formally diagnose dementia, particularly in early-stage or atypical dementia, but there is a place for ‘non-specialist’ healthcare professionals to identify and act on possible signs of dementia.

If dementia is suspected it is important to differentiate between dementia and other similarly presenting issues such as polypharmacy, depression, delirium or age-related cognitive decline.

This needs to be done by an appropriately skilled clinician if it is not within your scope of practice, but it is important to consider the following:

  • » The number of medications a person is taking and when they were last reviewed.

  • » The timeframe of decline in function and whether it is progressive.

  • » Are the person’s symptoms affecting their daily life?

  • » Are further investigations needed to investigate presenting symptoms?

Early detection

The opportunity to detect early-stage dementia in the community has been recognised, and guidance from the US outlines seven practice recommendations that encourage healthcare professionals to have more proactive conversations about dementia detection (Maslow and Fortinsky 2018):

» Make information about cognitive changes readily available to older people and their families.

  • » Be familiar with signs and symptoms of cognitive impairment.

  • » Listen to any concerns and observe for signs and symptoms of cognitive changes.

  • » Develop pathways and processes locally for referral and investigation.

  • » Use cognitive impairment tests to assess for cognitive changes.

  • » Support and encourage patients to follow through with referrals.

  • » Foster a greater understanding of dementia and its symptoms.

With appropriate training and knowledge, a healthcare professional could conduct a cognitive impairment test to determine whether further investigation is needed and if onward referral is required.

The sensitivity of these tests varies and they are often only validated in specialist settings, nevertheless they can be used to establish the need for further investigation (De Roeck et al 2019, Arevalo-Rodriguez et al 2021). However, to support wider use of these tests, further work must be done on licensing and education (Mattke et al 2023). For example, the commonly used Mini-Mental State Examination is proprietary and may require fees in certain cases (Mattke et al 2023).

The National Institute for Health and Care Excellence (NICE) (2019) states that people with suspected dementia should be referred to a specialist diagnostic service. This should follow full history taking, assessment using a validated brief cognitive testing tool and investigation or exclusion of reversible causes of cognitive decline (NICE 2018).

During discussion and assessment of suspected dementia it is important to provide clear advice and support to people. There should be adherence to the principles of the Mental Capacity Act 2005 and an appropriate care plan should be developed as required.

References

  1. Arevalo-Rodriguez I, Smailagic N, Roque-Figuls M et al (2021) Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews. Issue 7. CD010783. doi: 10.1002/14651858.CD010783.pub3
  2. Arvanitakis Z, Shah RC, Bennett DA (2019) Diagnosis and management of dementia: review. JAMA. 322, 16, 1589-1599. doi: 10.1176/appi.books.9780890425596
  3. Dementia UK (2023) What is Dementia? http://www.dementiauk.org/information-and-support/about-dementia/what-is-dementia/ (Last accessed: 30 July 2024.)
  4. Department of Health and Social Care (2024) Dementia Surveillance Factsheet. https://fingertips.phe.org.uk/documents/Dementia_Surveillance_England.html (Last accessed: 16 August 2024.)
  5. De Roeck EE, De Deyn PP, Dierckx E et al (2019) Brief cognitive screening instruments for early detection of Alzheimer’s disease: a systematic review. Alzheimer’s Research & Therapy. 11, 1, 21. doi: 10.1111/ggi.12014
  6. Maslow K, Fortinsky RH (2018) Nonphysician care providers can help to increase detection of cognitive impairment and encourage diagnostic evaluation for dementia in community and residential care settings. The Gerontologist. 58, Suppl 1, S20-S31. doi: 10.1111/j.1532-5415.2007.01289.x
  7. Mattke S, Batie D, Chodosh J et al (2023) Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care. Alzheimer’s & Dementia. 19, 9, 4252-4259. doi: 10.1016/j.jagp.2019.07.015
  8. National Institute for Health and Care Excellence (2018) Dementia: Assessment, Management and Support for People Living with Dementia and their Carers. NICE guideline No. 97. http://www.nice.org.uk/guidance/ng97 (Last accessed: 20 August 2024.)
  9. National Institute for Health and Care Excellence (2019) Dementia. Quality standard No. 184. http://www.nice.org.uk/guidance/qs184 (Last accessed: 20 August 2024.)
  10. Peters R, Booth A, Rockwood K et al (2019) Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open. 9, 1, e022846. doi: 10.1136/bmjopen-2018-022846.supp1

Share this page